Accurate diagnosis and effective treatment of Nasal related problems, snoring and Obstuctive Sleep Apnoea (OSA) are crucial to mitigate its associated health risks. These can include metabolic syndrome, and cognitive impairment, as well as heart disease, obesity and high blood pressure.
Serum biomarkers are valuable tools in the comprehensive diagnosis and treatment of OSA, as they provide valuable insight into the underlying mechanisms of OSA, such as inflammation, oxidative stress, and metabolic dysfunction.
Biomarkers can be used to effectively:
- Detection OSA early and assess the risk of associated complications
- Tailor personalised treatment strategies
- Monitor treatment efficacy for CPAP therapy, weight management and surgical options
Our clinic offers the most up-to-date screening tests that allow for early detection, thorough monitoring and effective management of the impact of obstructive nasal conditions, snoring and OSA.
